EDF Health

Selected tag(s): Industry tactics

The truth will out: Chemical industry’s deceptive tactics are eventually exposed

Richard Denison, Ph.D., is a Senior Scientist.

It’s hard not to get cynical in Washington, DC these days.  Just this past week, the American Chemistry Council (ACC) hosted an ice cream social on Capitol Hill – I kid you not.  ACC’s beckoning slogan:  “Join and learn about the benefits of chlorine chemistry and enjoy a tasty treat.”  I’m told hundreds of House staffers partook of this propaganda fest, at least the tasty treat part.  My initial reaction?  How can health and environmental advocates hope to compete?  Especially if one can successfully curry favor merely by offering a scoop of a staffer’s favorite flavor.

But just as I began to despair, Part I of a major exposé on a far more serious campaign of deception by the chemical industry ran on the front page of the Sunday Chicago Tribune.  (Actually, the article occupies virtually the entire front page of today’s edition.)   Read More »

Posted in Health science, Industry influence / Also tagged , , , , | Read 1 Response

Smoke and Mirrors: ACC lawyers are working hard to rein in your right to know

Richard Denison, Ph.D., is a Senior Scientist.

I’ve blogged here frequently about EPA’s efforts over the past couple of years to make more chemical information available to the public, especially health and safety information.  A key part of this, believe it or not, is simply making sure that when EPA shares a health study with the public – as required by law – you get to know the identity of the chemical that is the subject of that study.

EPA’s initial steps (see below) were met with a little grumbling on the part of the chemical industry, but not a whole lot.  After all, the industry says it wants the public to have more information about chemicals.  At #7 on the American Chemistry Council’s (ACC) top 10 principles for TSCA reform is:  “Companies and EPA should work together to enhance public access to chemical health and safety information.”

Times, apparently, have changed.  In recent weeks, ACC has launched a broadside attack on the EPA’s efforts to compel its member companies ever to name a chemical when submitting health and safety information to EPA.  My evidence?  A 36-page White Paper delivered by ACC to the office of the regulatory czar at the Office of Management and Budget, at a meeting held there on January 20.  The ACC document is a wonder of tortured logic, obfuscation and selective renditions of the history of TSCA.

Today, a response was mounted.  EDF and Earthjustice staff, as well as representatives of health-affected individuals, environmental justice communities and workers, held their own meeting with OMB officials.  And we delivered our own letter to OMB that thoroughly rebuts ACC’s White Paper.  It also points out that, way back in 1976, the drafters of TSCA actually wanted you to have access to health and safety information on chemicals – and they darn well didn’t expect you to have to guess at the identity of those chemicalsRead More »

Posted in Health policy, Industry influence, Regulation / Also tagged , , , , | Read 2 Responses

ACC resorts to smear tactics to defend its cash cows, formaldehyde and styrene

Richard Denison, Ph.D., is a Senior Scientist.

An increasingly common tactic in modern bare-knuckle politics is to divert attention away from your own weakness or vulnerability by loudly – and falsely – accusing your opponent of having that very defect you possess but won’t admit to.

That Rovian tactic was on display last week, with the American Chemistry Council (ACC) as the accuser, and the National Toxicology Program (NTP) as its “opponent.”  Mind you, NTP is the nation’s leading authoritative body on cancer-causing chemicals.

The precipitating event?  NTP’s long-overdue release of its 12th Report on Carcinogens (RoC).  Among other additions NTP made since its last report was published way back in 2005, it had the audacity – according to ACC – to:

  • upgrade its classification of formaldehyde to “Known to be a human carcinogen,” from its earlier classification (dating back to 1981) as “Reasonably anticipated to be a human carcinogen,” and
  • for the first time include styrene on its list of chemicals linked to cancer, classifying it as “reasonably anticipated to be a human carcinogen.”

The accusation hurled at NTP was this gem from ACC President and CEO, Cal Dooley:

“We are extremely concerned that politics may have hijacked the scientific process and believe this report by HHS is an egregious contradiction to what the President said early in his administration, ‘…That science and the scientific process must inform and guide decisions of my administration…’.”

Talk about the pot calling the kettle black (per the “second, subtler interpretation” of that phrase).

Read More »

Posted in Health policy, Industry influence, Regulation / Also tagged , , , , | Read 1 Response

ACC on Safe Chemicals Act of 2011: If you can’t say anything nice …

Richard Denison, Ph.D., is a Senior Scientist.

The Consumer Specialty Products Association found some nice things to say about it.  DuPont did too.  Even the National Petrochemical & Refiners Association acknowledged some improvements.

And the American Chemistry Council?  Read More »

Posted in Health policy, TSCA reform / Also tagged , , , | Comments are closed

House leadership asks White House to scrap IUR enhancements: Where are ACC’s principles now?

Richard Denison, Ph.D., is a Senior Scientist.

[Update:  Here are links to the Chairmen’s news release and letter to OMB.]

E&E News is reporting (subscription required) that House Energy & Commerce Committee Chairman Fred Upton has called on the White House to scrap the Environmental Protection Agency’s (EPA) soon-to-be-issued enhancements to the only routine reporting system for chemicals across the entire federal government.

The final EPA rule would expand EPA’s Inventory Update Reporting (IUR), which requires periodic reporting of chemicals subject to the Toxic Substances Control Act (TSCA).  The rule was sent to the Office of Management and Budget (OMB) on January 20 and is awaiting approval.

Chairman Upton’s move, in the form of a letter to OMB Director Jacob Lew cosigned by Environment and Economy Subcommittee Chairman John Shimkus, follows closely on the chemical industry’s loud complaints about the rule late last month at the GlobalChem conference, cosponsored by the American Chemistry Council (ACC) and the Society of Chemical Manufacturers and Affiliates (SOCMA).  What gives?  Read More »

Posted in Health policy, Regulation / Also tagged , , , , | Comments are closed

TSCA reform advocates to ACC: Give us something to work with!

Richard Denison, Ph.D., is a Senior Scientist.

An article just out in Chemical Week by senior editor Kara Sissel simply nails it in describing the state of affairs on TSCA reform as it played out at last week’s GlobalChem conference.

The captions under the side-by-side photos of American Chemistry Council (ACC) President Cal Dooley and yours truly tell it all.  Mr. Dooley laments the increasingly complex and unpredictable regulatory landscape that finally drove ACC to shift away from its longstanding opposition to TSCA reform.  But my plea that it is long past time for ACC to come forward with its own specific proposals for that reform speaks to where things have been stuck for much of the past year.  Read More »

Posted in Health policy, TSCA reform / Also tagged | Comments are closed